Investing.com - Hologic reported on Wednesday third quarter earnings that beat analysts' forecasts and revenue that topped expectations.
Hologic announced earnings per share of $0.95 on revenue of $1B. Analysts polled by Investing.com anticipated EPS of $0.7121 on revenue of $904.49M.
Hologic shares are down 16% from the beginning of the year and are trading at $70.00 , down-from-52-week-high.They are outperforming the Nasdaq which is down 23.09% from the start of the year.
Hologic shares lost 1.33% in after-hours trade after the report.
Hologic follows other major Healthcare sector earnings this month
Hologic's report follows an earnings beat by UnitedHealth on Friday, July 15, 2022, who reported EPS of $5.57 on revenue of $80.33B, compared to forecasts EPS of $5.21 on revenue of $79.68B.
J&J had beat expectations on Tuesday, July 19, 2022 with second quarter EPS of $2.59 on revenue of $24.02B, compared to forecast for EPS of $2.54 on revenue of $23.77B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar